Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria.
Heerspink HJ, Provenzano M, Vart P, Jongs N, Correa-Rotter R, Rossing P, Mark PB, Pecoits-Filho R, McMurray JJ, Langkilde AM, Wheeler DC, Toto RB, Chertow GM. Heerspink HJ, et al. Among authors: provenzano m. Am Heart J. 2024 Apr;270:125-135. doi: 10.1016/j.ahj.2024.02.006. Epub 2024 Feb 15. Am Heart J. 2024. PMID: 38367893 Free article. Clinical Trial.
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.
Provenzano M, Chiodini P, Minutolo R, Zoccali C, Bellizzi V, Conte G, Locatelli F, Tripepi G, Del Vecchio L, Mallamaci F, Di Micco L, Russo D, Heerspink HJL, De Nicola L. Provenzano M, et al. Nephrol Dial Transplant. 2020 Jan 1;35(1):138-147. doi: 10.1093/ndt/gfy217. Nephrol Dial Transplant. 2020. PMID: 30053127
Association Between Renal Function and Troponin T Over Time in Stable Chronic Kidney Disease Patients.
Chesnaye NC, Szummer K, Bárány P, Heimbürger O, Magin H, Almquist T, Uhlin F, Dekker FW, Wanner C, Jager KJ, Evans M; EQUAL Study Investigators †; EQUAL Study Investigators<xref ref-type="author-note" rid="jah34480-note-0002"><sup>†</sup></xref>. Chesnaye NC, et al. J Am Heart Assoc. 2019 Nov 5;8(21):e013091. doi: 10.1161/JAHA.119.013091. Epub 2019 Oct 30. J Am Heart Assoc. 2019. PMID: 31662068 Free PMC article.
Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan's Efficacy: A Post Hoc Analysis from the SONAR Trial.
Waijer SW, de Vries ST, Busch R, Xie D, Gansevoort RT, Hou FF, Górriz JL, Laverman GD, De Nicola L, Pascual J, Provenzano M, Pergola PE, Tang SCW, Wanner C, Zaoui P, Parving HH, de Zeeuw D, Heerspink HJL. Waijer SW, et al. Among authors: provenzano m. J Am Soc Nephrol. 2021 Nov;32(11):2731-2734. doi: 10.1681/ASN.2021040498. Epub 2021 Aug 20. J Am Soc Nephrol. 2021. PMID: 34417318 Free PMC article. No abstract available.
The Kidney Protective Effects of the Sodium-Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists.
Provenzano M, Jongs N, Vart P, Stefánsson BV, Chertow GM, Langkilde AM, McMurray JJV, Correa-Rotter R, Rossing P, Sjöström CD, Toto RD, Wheeler DC, Heerspink HJL; DAPA-CKD Trial Committees and Investigators. Provenzano M, et al. Kidney Int Rep. 2021 Dec 14;7(3):436-443. doi: 10.1016/j.ekir.2021.12.013. eCollection 2022 Mar. Kidney Int Rep. 2021. PMID: 35257056 Free PMC article.
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial.
Provenzano M, Puchades MJ, Garofalo C, Jongs N, D'Marco L, Andreucci M, De Nicola L, Gorriz JL, Heerspink HJL; ROTATE-3 study group; ROTATE-3 study group members. Provenzano M, et al. J Am Soc Nephrol. 2022 Aug;33(8):1569-1580. doi: 10.1681/ASN.2022020207. Epub 2022 Apr 19. J Am Soc Nephrol. 2022. PMID: 35440501 Free PMC article. Clinical Trial.
Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post-hoc analysis of the ROTATE-3 study.
Lieverse TTGF, Puchades MJ, Mulder UDJ, Provenzano M, Krenning G, Jongs N, Wink SE, Slart RHJA, Andreucci M, D'Marco L, De Nicola L, Gorriz JL, Heerspink HJL. Lieverse TTGF, et al. Among authors: provenzano m. Diabetes Obes Metab. 2024 Feb;26(2):576-582. doi: 10.1111/dom.15346. Epub 2023 Nov 5. Diabetes Obes Metab. 2024. PMID: 37926904 Clinical Trial.
[Semaglutide in Chronic Kidney Disease: Great Enthusiasm. But How Does It Work?].
Iorio F, Summaria C, Greco R, Leone F, Gigliotti P, Arena R, Talarico R, Senatore M, Mollica F, Tosti F, Zingone F, Di Vilio R, Mollica A, Papalia T, Napoletano A, Vaccarisi S, Provenzano M, Zaza G. Iorio F, et al. Among authors: provenzano m. G Ital Nefrol. 2024 Jun 28;41(3):2024-vol3. doi: 10.69097/41-03-2024-04. G Ital Nefrol. 2024. PMID: 38943325 Review. Italian.
298 results